May 2023 Update: A Summary of What’s Happened So Far
On February 9, 2023, a Florida woman filed a lawsuit against EzriCare artificial tears, citing a resistant bacterial infection that caused her unrelenting pain after using the eye drops.
This came a week after EzriCare issued a nationwide recall due to possible bacterial contamination of Pseudomonas aeruginosa in their eye drops.
Since that first lawsuit was filed, the CDC has registered 81 cases across 18 states of infections caused by EzriCare eye drops.
Delsam has also issued recalls for contaminated eye drops; Delsam distributes eye drops from the same manufacturer as EzriCare.
Out of these 81 infections, there have been four deaths, four cases of eyeballs being surgically removed, and 14 cases of vision loss.
Symptoms of possible infection typically include yellow, green or clear discharge from the eye; eye or eyelid redness; the sensation of something being in the eye; increased sensitivity to light; or blurry vision.
In April of this year, an FDA inspection of the facility where the EzriCare and Delsam eye drops are produced concluded that the manufacturing process lacked measures to ensure product sterility, specifically in product batches that were produced between December 2020 and April 2022.
Some of their findings showed that the water filtration system was not fully functioning and that the airflow in the factory’s aseptic cleaning rooms were limited.
Both of these instances can create conditions that allow bacteria to flourish.
This lawsuit is still in early pre-trial stages, and new cases of infection are still being discovered.
If you used EzriCare or Delsam eye drops and subsequently suffered from eye pain, injury, or infection you may be eligible to file an EzriCare Artificial Tears Lawsuit.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for a EzriCare Artificial Tears Lawsuit instantly.